Jump to content

Wieland Schinnenburg

From Wikipedia, the free encyclopedia
Wieland Schinnenburg
Wieland Schinnenburg in 2020
Member of the Bundestag
Assumed office
2017
Personal details
Born (1958-11-12) 12 November 1958 (age 66)
Norden, West Germany
(now Germany)
Political partyFDP
Children3
OccupationDentist and lawyer

Wieland Schinnenburg (born 12 November 1958) is a German politician. Born in Norden, Lower Saxony, he represents the Free Democratic Party (FDP). Wieland Schinnenburg has served as a member of the Bundestag from the state of Hamburg since 2017.[1]

Life

Wieland Schinnenburg studied dentistry from 1978 to 1984 at the Medical University of Hannover and the Westphalian Wilhelms University in Münster. After his state examination, he received his doctorate in 1985 and worked as an employed dentist from 1984 to 1987. From 1987 until his election to the German Bundestag in 2017 he ran his own practice in Oststeinbek near Hamburg. In addition to his work as a dentist, he began studying law at the University of Hamburg in 1989, which he completed in 1994 with the First State Examination; in 1997, he took the Second State Examination at the Higher Regional Court of Celle. During his studies, he completed study visits and internships in Port-au-Prince, Los Angeles, Chiang Mei, Jerusalem and Washington, D.C. In 1998, Schinnenburg opened a law firm in addition to his dental practice. Since 2006, Schinnenburg has been a specialist lawyer for medical law and since 2007 a mediator.

He became member of the bundestag after the 2017 German federal election. Member of the Committee on Health and Deputy Member of the Committee on Legal Affairs and Deputy Chairman of the German-Korean Parliamentary Group. For the FDP parliamentary group he is the spokesman for drug and addiction policy.[2]

References

  1. ^ "Wieland Schinnenburg | Abgeordnetenwatch". www.abgeordnetenwatch.de (in German). Retrieved 2020-03-16.
  2. ^ "Fachpolitische Sprecher". Fraktion der Freien Demokraten im Deutschen Bundestag (in German). Retrieved 2020-03-16.